| Study | Treatment arms | p-value | |
|---|---|---|---|
| Vásquez-Garibay et al. 200582 | Added NTs (n = 11) | No added NTs (n = 9) | a |
| Mean W/L z-score ± SD | |||
| Week 1 | −2.80 ± 0.73 | −2.99 ± 0.74 | |
| Week 4 | −0.64 ± 0.66b | −0.94 ± 0.47b | |
| Mean initial BMI ± SD | 11.0 ± 0.9 | 10.6 ± 1.0 | 0.33 |
| Mean fourth week BMI ± SD | 15.1 ± 1.0 | 14.5 ± 1.0 | 0.23 |
| Mean skin fold ± SD, mm | |||
| Triceps,b initial week | 3.8 ± 1.0 | 2.8 ± 0.6 | 0.031 |
| Triceps, fourth week | 9.2 ± 2.6 | 8.5 ± 1.6 | 0.517 |
| Subscapular,c initial week | 2.9 ± 0.7 | 2.4 ± 0.6 | 0.076 |
| Subscapular, fourth week | 8.1 ± 2.7 | 6.4 ± 1.1 | 0.112 |
| Subcostal,c initial week | 2.3 ± 0.5 | 1.8 ± 0.3 | 0.045 |
| Subcosta, fourth week | 5.5 ± 1.9 | 4.0 ± 0.6 | 0.004 |
| Suprailiac,c initial week | 2.2 ± 0.5 | 1.7 ± 0.3 | 0.020 |
| Suprailiac, fourth week | 5.7 ± 2.5 | 4.2 ± 0.6 | 0.114 |
BMI, body mass index.
Some p-values are differences between groups. Because of the absence of further notations, it is uncertain which p-values are for within-group and which for between-group differences.
Increase in W/L z-score from initial to week 4 was significant within groups (added NTs p < 0.001, no added NTs p = 0.001).
Denotes p < 0.001; initial vs fourth week within each group.
From: 4, Assessment of clinical effectiveness
Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.